Ticagrelor Versus Clopidogrel in Prevention of No Reflow

Adequacy of coronary flow can be judged upon using several methods like TIMI Grade and myocardial blush grade. No-reflow phenomenon, defined as incomplete reperfusion at the microvascular level despite adequate patency of the occluded artery, remains an important limitation of primary percutaneous intervention in STEMI patients nowadays. We aim in this study to investigate the relationship between the antiplatelet loading dose whether to be Ticagrelor or Clopidogrel and post intervention coronary flow, bleeding risk in these patients.Aim of the Work: To compare between the effects of preoperative loading dose of Ticagrelor and clopidogrel in Diabetic STEMI patients undergoing primary percutaneous coronary intervention regarding prevention of no reflow, Instent thrombosis and short term bleeding risk. Myocardial reperfusion was judged upon using TIMI Grade and myocardial blush grade.

Autorentext
Dr. Mohamed Gamal Elshawa, 30 years old, works as Assistant lecturer of Cardiology, at Ainshams University, graduated from faculty of medicine Ainshams University since 2018. He got MSc of Cardiology since 2022.